How Risky Is a Second Allogeneic Stem Cell Transplantation?

In historic publications, a very high non-relapse mortality has been described, arguing against performing a second allogeneic stem cell transplantation (alloSCT). Investigators analyzed the outcome of 3356 second alloSCT performed 2011–21 following a hematologic malignancy relapse.